Nuveen Municipal Credit Opportunities Fund has announced a transferable rights offering at a 1-for-4 ratio, expiring October 7, 2026. Shareholders as of September 8, 2026, will receive rights allowing them to subscribe at a price set at the higher of 95% of the market price or 90% of the net asset value, ensuring at least a 10% discount. Nuveen will cover all offering expenses, which aligns manager interests positively and is expected to improve liquidity and reduce the fund's expense ratio. Investors may consider a sell-and-rebuy strategy to benefit from discount fluctuations, but subscription decisions will depend on the discount level at the offering's expiry.
Elizabeth Crain, a director at Core Scientific, has purchased 6,000 shares of the company. This insider buying may indicate her confidence in the company's future prospects. Such moves often attract investor attention as they can signal positive expe...
Hyperscale Data has stopped Bitcoin mining to focus on AI data center services, backed by a $1.2 billion contract at its Michigan facility. The company's assets, including cash and Bitcoin, are worth nearly double its market cap, suggesting undervalu...
Casey's General Stores reported strong Q1 2026 results, surpassing analyst expectations with an EPS of $7.37 versus $6.78 estimated and revenue of $5.68 billion beating the $5.56 billion forecast. Net income rose 27.1% year-over-year to $273.7 millio...
Academy Sports and Outdoors will announce its Q2 2026 earnings on September 9, with revenue expected to rise 3.8% year-over-year to about $1.66 billion. Analysts forecast earnings per share between $2.07 and $2.12, up from $1.94 last year, indicating...
Pharvaris's experimental oral drug deucrictibant showed an 83% reduction in hereditary angioedema (HAE) attacks in a Phase 3 trial, prompting Oppenheimer to raise its price target from $50 to $75 and maintain an "Outperform" rating. The positive tria...
